Showing results (1171-1180 of 1,246) with videos related to

Sort By:
Pageof 125
JCI Insight|September 22, 2022
Lower SARS-CoV-2-specific humoral immunity in people living with HIV-1 recovered from nonhospitalized COVID-19Daniel J Schuster, Shelly Karuna, Caroline Brackett, et al.
The Journal of Clinical Investigation|June 24, 2021
Rectal tissue and vaginal tissue from intravenous VRC01 recipients show protection against ex vivo HIV-1 challengeRena D Astronomo, Maria P Lemos, Sandeep R Narpala, et al.
BMC Geriatrics|June 15, 2024
Interventions that have potential to help older adults living with social frailty: a systematic scoping reviewMonika Kastner, Isabella Herrington, Julie Makarski, et al.
Eclinicalmedicine|May 9, 2020
A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South AfricaLinda-Gail Bekker, One Dintwe, Andrew Fiore-Gartland, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2024
Phase I Study of ROR1-Specific CAR-T Cells in Advanced Hematopoietic and Epithelial MalignanciesCarla A Jaeger-Ruckstuhl, Jennifer M Specht, Jenna M Voutsinas, et al.
JCI Insight|October 8, 2024
Identification of RTS,S/AS01 vaccine-induced humoral biomarkers predictive of protection against controlled human malaria infectionRachel L Spreng, Kelly E Seaton, Lin Lin, et al.
Antibiotics (Basel, Switzerland)|December 23, 2022
Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the FutureZikria Saleem, Brian Godman, Aislinn Cook, et al.
The Lancet. Microbe|June 8, 2021
Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort studyClark D Russell, Cameron J Fairfield, Thomas M Drake, et al.
Medrxiv : the Preprint Server for Health Sciences|July 15, 2024
Tumor Regression Following Engineered Polyomavirus-Specific T Cell Therapy in Immune Checkpoint Inhibitor-Refractory Merkel Cell CarcinomaYuta Asano, Joshua Veatch, Megan McAfee, et al.
Frontiers in Immunology|May 29, 2025
Retrospective analysis of sex-disaggregated immune responses to ALVAC-HIV and bivalent subtype C gp120/MF59 HIV vaccinesCassie G Ackerley, Srilatha Edupuganti, Chenchen Yu, et al.
Pageof 125